Letermovir for Cytomegalovirus Prophylaxis in Patients With T-PLL Treated With Alemtuzumab.
Document Type
Article
Publication Title
Clinical lymphoma, myeloma & leukemia
First Page
1
Last Page
3
DOI
10.1016/j.clml.2026.06.015
Publication Date
6-28-2026
Recommended Citation
Reneau JC, Huang Y, Braunstein Z, Hanel W, Chung CG, Brammer JE, William BM. Letermovir for Cytomegalovirus Prophylaxis in Patients With T-PLL Treated With Alemtuzumab. Clin Lymphoma Myeloma Leuk. 2026 Jun 28:S2152-2650(26)00202-8. doi: 10.1016/j.clml.2026.06.015. Epub ahead of print. PMID: 42502036.
COinS